FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Office of Clinical Pharmacology Good Review Practices

[ Price : $8.95]

CDER issues a MAPP outlining good review practices for the Office of Clinical Pharmacology review of NMEs, NDAs, and BLAs.

FDA Clears GI View Aer-O-Scope

[ Price : $8.95]

FDA clears a GI View Ltd. 510(k) for its new Aer-O-Scope Colonoscope System, a disposable, self-propelled, joystick-controlled, co...

Magnetic Surgical Instrument Device Classified as Class 2

[ Price : $8.95]

Federal Register Final Order: FDA classifies the Magnetic Surgical Instrument System into Class 2 (special controls).

Product Radiation Committee to Mull Device Performance Standards

[ Price : $8.95]

Federal Register Notice: FDA announces a 10/25-26 public advisory committee meeting of the Technical Electronic Product Radiation ...

Strabismus Detection Device Into Class 2

[ Price : $8.95]

Federal Register Final Order: FDA classifies the strabismus detection device into Class 2 (special controls).

FDA to Help With Legislation to Curb Generic Drug Delays

[ Price : $8.95]

CDER director Janet Woodcock says the agency is interested in providing technical expertise on legislation that could curb brand n...

FDA Fast Track Status for Malaria Vaccine

[ Price : $8.95]

FDA grants Sanaria a fast track designation for its preventative vaccine for malaria, Sanaria PfSPZ Vaccine.

CGMP Violations in Hebei Yuxing Inspection

[ Price : $8.95]

FDA warns Hebei Yuxing Bio-Engineering about CGMP deviations in its manufacturing of active pharmaceutical ingredients, and places...

FDA Lab Test Proposal is Double Regulation: Senator

[ Price : $8.95]

Sen. Lamar Alexander criticizes an FDA proposal to regulate all laboratory-developed tests now regulated under the Clinical Labora...

CDER Office of Surveillance and Epidemiology MAPP

[ Price : $8.95]

CDER issues a MAPP with procedures the Office of Surveillance and Epidemiology follows when it reviews proposed drug proprietary n...